New Jersey sues OxyContin maker, claims it misled public

<p>The state claims Purdue exploited vulnerable new markets, including the elderly and the &quot;opioid-na&iuml;ve,&quot; to boost profits.</p>

News 12 Staff

Oct 31, 2017, 3:45 PM

Updated 2,362 days ago

Share:

TRENTON, N.J. (AP) -- New Jersey is suing the company that manufactures OxyContin, claiming a "direct link" between the state's opioid crisis and the firm's deceptive marketing practices.
State Attorney General Christopher Porrino says the five-count lawsuit against Connecticut-based Purdue Pharma and two of its entities was filed Tuesday. It seeks undisclosed monetary damages for fraud and false claims.
Purdue Pharma issued a statement saying it "vigorously denies" the allegations. The company says it's deeply troubled by the opioid crisis and is dedicated to being part of the solution.
The state claims Purdue exploited vulnerable new markets, including the elderly and the "opioid-naïve," to boost profits. It claims Purdue aggressively marketed opioids and duped doctors and the public into believing they should be the primary treatment option for chronic conditions like arthritis and migraines.
Copyright 2017 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.


More from News 12